SURGIVANCE INC.
Confocal-based surgical pathology system for real-time intraoperative tissue imaging
- Sector
- Medtech
- Headquarters
- New York, NY
- Total capital
- $6.6M
- Federal grants
- $6.6M
- 9 awards · 2019–2026
- Rank in peer group#23 of 477
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 4 pending · first 2019
- Rank in peer group#118 of 477
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demand$1.3M
- Federal grantHealth and Human S · Phase II · Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demand$978K
- Federal grantHealth and Human S · Phase II · Advanced Surgical Pathology Device$1M
- Federal grantHealth and Human S · Phase II · Advanced Surgical Pathology Device$1M
- Federal grantHealth and Human S · Phase II · Advanced Surgical Pathology Device$1M
- Federal grantNSF · Phase I · SBIR Phase I:Digitizing The Pathologist In The Operating Room$276K
- Federal grantHealth and Human S · Phase I · Advanced Surgical Pathology Device$193K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · Advanced Surgical Pathology Device$493K
- Federal grantHealth and Human S · Phase I · Advanced Surgical Pathology Device$300K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#23 · top 5%
- Granted patents#118 · top 25%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 6- PendingSystems And Methods For Tissue ImagingUSPTOApplication 18931807
- PendingSystems And Methods For Tissue StainingUSPTOApplication 18646604
- GrantedLine-scanning, Sample-scanning, Multimodal Confocal MicroscopeUSPTOUS 11,391,936
Show all 6 patent records
- Systems And Methods For Tissue ImagingFeb 13, 2025 · Application 18931807Pending
- Systems And Methods For Tissue StainingOct 31, 2024 · Application 18646604Pending
- Line-scanning, Sample-scanning, Multimodal Confocal MicroscopeJul 19, 2022 · US 11,391,936Granted
- Line-scanning, Sample-scanning, Multimodal Confocal MicroscopeNov 5, 2019 · US 10,466,460Granted
- Systems And Methods For Tissue ImagingApplication PCTUS2024053589Pending
- Cassette Having Magnetically Coupled Front And Back Parts For Performing Rapid Tissue Pathology And Methods Of Use ThereofApplication 63522542Pending
Related companies, and why
- ASTRIA BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
- Noveratech L.L.C.Similar federal contract value in Medtech · null in contracts
- DMG Practice Management Solutions LLCSimilar federal contract value in Medtech · null in contracts
- OCULO THERAPY LLCSimilar federal contract value in Medtech · null in contracts
- LX MedicalSimilar federal contract value in Medtech · null in contracts
- NanoSynth Materials and Sensors Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .